A number of investment brokers have recently updated their price targets on shares of CareDx, Inc. (CDNA). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/21/2016 – CareDx, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 7 price target on the stock.

04/20/2016 – CareDx, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 6 price target on the stock.

02/10/2016 – Janney Montgomery Scott began new coverage on CareDx, Inc. giving the company a “buy” rating. They now have a USD 12 price target on the stock.

11/18/2015 – CareDx, Inc. had its “buy” rating reiterated by analysts at Craig-Hallum. They now have a USD 13 price target on the stock.

09/29/2015 – CareDx, Inc. was downgraded to “market perform” by analysts at Raymond James.

05/13/2015 – CareDx, Inc. was downgraded to “sell” by analysts at Zacks.

03/18/2015 – CareDx, Inc. had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 12 price target on the stock.

The share price of CareDx, Inc. (CDNA) was up +4.56% during the last day of trading, with a day high of 4.37. 9429 shares were traded during the last session.

The stock’s 50 day moving average is 4.75 and its 200 day moving average is 5.24. The stock’s market capitalization is 51.89M. CareDx, Inc. has a 52-week low of 3.70 and a 52-week high of 8.00.

View other investors thoughts on CareDx, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.